Innovita Biological Technology Co., Ltd. (SHA:688253)
China
· Delayed Price · Currency is CNY 48.26
+1.72 (3.70%)
At close: Apr 29, 2026
SHA:688253 Market Cap
SHA:688253 has a market cap or net worth of 6.51 billion as of April 29, 2026. Its market cap has increased by 36.67% in one year.
Market Cap
6.51B
Enterprise Value
4.67B
Revenue
422.03M
Ranking
n/a
PE Ratio
45.10
Stock Price
48.26
Market Cap Chart
Since July 28, 2022, SHA:688253's market cap has increased from 4.49B to 6.51B, an increase of 44.96%. That is a compound annual growth rate of 10.40%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 28, 2026 | 6.28B | 54.21% |
| Dec 31, 2025 | 4.07B | -17.74% |
| Dec 31, 2024 | 4.95B | 45.41% |
| Dec 29, 2023 | 3.40B | 5.00% |
| Dec 30, 2022 | 3.24B | -27.82% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Xiangxue Pharmaceutical | 6.28B |
| R&G PharmaStudies | 6.39B |
| Lifecome Biochemistry | 6.02B |
| Shenzhen Weiguang Biological Products | 5.91B |
| PharmaResources (Shanghai) | 5.90B |
| Novogene | 5.73B |
| Kexing Biopharm | 5.70B |
| Wuhan Hvsen Biotechnology | 5.70B |